EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Tirzepatide in type 1 diabetes: beyond mere weight loss

Theodoros Panou, Evanthia Gouveri, Djordje S Popovic, Nikolaos Papanas

Expert Review of Clinical Pharmacology · 03.07.2026 · 19 (7) · 687-696

DOI: 10.1080/17512433.2026.2685653 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Expert Review of Clinical Pharmacology, online erschienen am 11.06.2026. Verfasst von Theodoros Panou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Centre-Diabetic Foot Clinic, Second Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece. Hauptthemen laut MEDLINE: Tirzepatide, Diabetes Mellitus, Type 1, Hypoglycemic Agents, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit nennt 85 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TirzepatideDiabetes Mellitus, Type 1Hypoglycemic AgentsGlucagon-Like Peptide-1 Receptor AgonistsHumansWeight LossAnimalsInsulinObesityGlycated HemoglobinContinuous Glucose MonitoringBlood GlucoseBody Mass IndexReceptors, Gastrointestinal Hormone

Stichwörter der Autor:innen

Type 1 diabetes mellitusglucagon-like peptide-1 receptorglucagon-like peptide-1 receptor agonistsglucose-dependent insulinotropic polypeptide receptortirzepatide

Substanzen

TirzepatideHypoglycemic AgentsGlucagon-Like Peptide-1 Receptor AgonistsInsulinGlycated Hemoglobingastric inhibitory polypeptide receptorBlood Glucosehemoglobin A1c protein, humanReceptors, Gastrointestinal Hormone

Autor:innen und Institutionen

  • Diabetes Centre-Diabetic Foot Clinic, Second Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
  • Clinic for Endocrinology, Diabetes and Metabolic Disorders, Clinical Center of Vojvodina, Novi Sad, Serbia.
  • Medical Faculty, University of Novi Sad, Novi Sad, Serbia.

Zitieren

APA

Panou, T., Gouveri, E., Popovic, D. S., & Papanas, N. (2026). Tirzepatide in type 1 diabetes: beyond mere weight loss. Expert Review of Clinical Pharmacology, 19(7), 687-696. https://doi.org/10.1080/17512433.2026.2685653

Vancouver

Panou T, Gouveri E, Popovic DS, Papanas N. Tirzepatide in type 1 diabetes: beyond mere weight loss. Expert Review of Clinical Pharmacology. 2026;19(7):687-696. doi:10.1080/17512433.2026.2685653

BibTeX
@article{Panou2026,
  author = {Panou, Theodoros and Gouveri, Evanthia and Popovic, Djordje S and Papanas, Nikolaos},
  title = {Tirzepatide in type 1 diabetes: beyond mere weight loss},
  journal = {Expert Review of Clinical Pharmacology},
  year = {2026},
  volume = {19},
  number = {7},
  pages = {687--696},
  doi = {10.1080/17512433.2026.2685653}
}
Kostenlos starten →